Market Snapshot

Forecast Years for Road Side Drug Testing Devices Market:	2022 - 2028
Historical Years for Road Side Drug Testing Devices Market:	2016 - 2021
Revenue 2021 for Road Side Drug Testing Devices Market:	USD 713.1 Million
Revenue 2028 for Road Side Drug Testing Devices:	USD 891.9 Million
Revenue CAGR (2022 - 2028) for Road Side Drug Testing Devices Market :	3.8%
Fastest Growing Region (2022 - 2028) for Road Side Drug Testing Devices Market:	Asia Pacific
Largest Region (2021) for Road Side Drug Testing Devices Market:	North America

Market Synopsis:

The Global Road Side Drug Testing Devices Market was valued USD 713.1 Million in the year 2021 and is anticipated to reach a value of USD 891.9 Million by the year 2028. The Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 3.8% over the forecast period.

The laws for more frequently used roadside drug testing devices have been strengthened globally due to the increased focus on guaranteeing motor vehicle safety. Such gadgets can run roadside drug tests utilizing the accused's bodily fluid samples. The development of fast drug misuse detection technology has led to a substantial increase in the demand among law enforcement agencies for roadside drug testing equipment. The market for roadside drug testing devices is believed to be driven primarily by the convenience and accuracy of utilizing such handheld equipment on the spot.

As consumers become more conscious of government benefits, rules, and strict law enforcement, the market for roadside drug testing equipment is anticipated to grow. Adopting quick test devices for drug and alcohol testing or identification is expected to drive the global roadside drug testing devices market during the forecast period. Due to an increase in traffic accidents, there is a growing need for devices that test for drugs on the side of the road. Both developed and developing countries often sell roadside drug testing equipment.

In addition, the market for roadside drug testing equipment has a significant development opportunity due to the surge in drink-spiking at amusement parties. However, the sales of roadside drug testing devices may suffer due to poor or false-negative detection caused by biological samples, such as body fluids, collected from the victim's body later. The demand for roadside drug testing equipment is further constrained by many other restrictions, such as the larger volume of samples needed for detection. Roadside drug testing device market share growth is primarily constrained by device operation in cold-weather conditions.

Market Segmentation:

The Road Side Drug Testing Devices Market is segmented into substance, sample type, End user, and modality. Based on substance, the market is segmented as drugs and alcohol. Based on sample type, the market is segmented as Saliva, Sweat, Urine, and Others. Based on modality, the market is segmented as Handheld and Standalone. Based on End-User, the market is divided into Highway Police, Drug Enforcement Agencies and others.

Based on Substance:

The market is divided into drugs and alcohol based on substance. The alcohol segment will dominate the Road Side Drug Testing Devices market over the forecast period. This is because the most commonly abused substance among drivers is alcohol. The global market for roadside drug testing equipment is expanding faster than average due to rising alcohol consumption and a rise in the number of incidents of drunk driving. Additionally, the increase in the impact of alcohol misuse on public health and the licensing of roadside drug testing equipment contribute to expanding the global market.

Based on Sample type:

The market can be divided into categories for urine, sweat, saliva, and other sample types. The other segment holds the highest market share, which includes breath specimens. The most typical sample used to identify alcohol is breath. The most commonly abused substance among drivers is alcohol. With the simplicity of breathalyzers, Manufacturers also concentrate on creating quick tests that, compared to lab tests, offer shorter findings, are simple to use, and are less expensive. The saliva segment is likely to grow fastest during the forecast period. In many nations, roadside oral fluid or saliva testing is primarily employed to check for the presence of narcotics.

Asia Pacific is Projected to Grow at the Fastest CAGR during the Forecast Period

Asia Pacific is accounted to grow at the fastest CAGR during the forecast period. The prevalence of drinking facilities staying open for entertainment raises the risk of accidents caused by intoxication and fuels demand for roadside drug testing equipment. The rise in drug and alcohol usage among young people and the elderly, as well as the worrying number of fatalities resulting from drink-driving accidents, are factors that are predicted to support the expansion of the global market for roadside drug testing equipment in this area. The demand for roadside drug testing equipment in the area is anticipated to increase due to changing lifestyles and late-night working hours that encourage drinking and driving. Additionally, more effective and alert law enforcement organizations are expected to support the region's sales of roadside drug testing equipment.

Competitive Landscape:

The key players in the Global Road Side Drug Testing Devices Market include- Dragerwerk AG & Co. KgaA, AK GlobalTech Corporation, Abbott Laboratories, MAVAND Solutions GmbH, Oranoxis Inc., Pacific Data Systems Pty Ltd., CareHealth America, UriTox LLC, Cannabix Technologies Inc., Alcohol Countermeasure Systems Corp., and others.

Segmentation of the Global Road Side Drug Testing Devices Market:

Parameter	Details
Segments Covered	Modality (Standalone, Handheld) Substance (Drugs, Alcohol) Sample Type (Saliva, Urine, Sweat, Others) End User (Highway Police, Drug Enforcement Agencies, Others) Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered	North America - (U.S., Canada, Mexico) Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe) Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific) Latin America - (Brazil, Argentina, Rest Of Latin America) Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered	Dragerwerk AG & Co. KgaA AK GlobalTech Corporation Abbott Laboratories MAVAND Solutions GmbH Oranoxis Inc. Pacific Data Systems Pty Ltd. CareHealth America UriTox LLC Cannabix Technologies Inc. Alcohol Countermeasure Systems Corp.
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis